Mike Berry

2.3k total citations · 1 hit paper
15 papers, 1.8k citations indexed

About

Mike Berry is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Mike Berry has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Mike Berry's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (7 papers) and IL-33, ST2, and ILC Pathways (3 papers). Mike Berry is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (7 papers) and IL-33, ST2, and ILC Pathways (3 papers). Mike Berry collaborates with scholars based in United Kingdom, Australia and Italy. Mike Berry's co-authors include Christopher E. Brightling, Ian Pavord, Andrew J. Wardlaw, Dominick Shaw, Ruth H. Green, Yassine Amrani, Peter Bradding, Beverley Hargadon, M. Shelley and Debbie Parker and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Mike Berry

15 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma

2006 631 citations Mike Berry, Beverley Hargadon et al. New England Journal of Medicine profile →

Peers

Mike Berry

PHYSI

PRM

IMMUN

IA

SURGE

G Kolarz Austria

Daisuke Ichikawa Japan

Weiguo Xu China

Weihong Han United States

David L. J. Freed United Kingdom

Wei Qian China

Christine Chan United States

Lihua Duan China

Shwetha K. Shetty United States

Evangelia Zampeli Greece

G Kolarz Austria

Mike Berry

99 ×0.1

PHYSI

108 ×0.1

PRM

106 ×0.2

IMMUN

79 ×0.3

IA

141 ×0.8

SURGE

Citations per year, relative to Mike Berry Mike Berry (= 1×) peers G Kolarz

Countries citing papers authored by Mike Berry

Since Specialization

Citations

This map shows the geographic impact of Mike Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Berry more than expected).

Fields of papers citing papers by Mike Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Berry. The network helps show where Mike Berry may publish in the future.

Co-authorship network of co-authors of Mike Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Berry. A scholar is included among the top collaborators of Mike Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Berry. Mike Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Berry, Mike. (2016). Technology Focus: Artificial Lift. Journal of Petroleum Technology. 68(7). 67–67. 2 indexed citations

2.

Shaw, Dominick, Ruth Green, Mike Berry, et al.. (2012). A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma. Primary Care Respiratory Journal. 21(3). 283–287. 33 indexed citations

3.

Berry, Mike, Salman Siddiqui, Angela Morgan, et al.. (2008). Increased sputum and bronchial biopsy IL-13 expression in severe asthma. Journal of Allergy and Clinical Immunology. 121(3). 685–691. 201 indexed citations

4.

Shaw, Dominick, Mike Berry, Mike Thomas, et al.. (2007). The Use of Exhaled Nitric Oxide to Guide Asthma Management. American Journal of Respiratory and Critical Care Medicine. 176(3). 231–237. 254 indexed citations

5.

Brightling, Christopher E., Mike Berry, & Yassine Amrani. (2007). Targeting TNF-α: A novel therapeutic approach for asthma. Journal of Allergy and Clinical Immunology. 121(1). 5–10. 293 indexed citations

6.

Heffler, Enrico, Mike Berry, & Ian Pavord. (2007). Tumor Necrosis Factor-α. BioDrugs. 21(6). 345–349. 18 indexed citations

7.

Kitchenham, Barbara, Mike Berry, Karl Cox, et al.. (2007). Evaluating guidelines for reporting empirical software engineering studies. Empirical Software Engineering. 13(1). 97–121. 85 indexed citations

8.

Woodman, Lucy, Amanda Sutcliffe, Davinder Kaur, et al.. (2006). Chemokine Concentrations and Mast Cell Chemotactic Activity in BAL Fluid in Patients With Eosinophilic Bronchitis and Asthma, and in Normal Control Subjects. CHEST Journal. 130(2). 371–378. 23 indexed citations

9.

Kitchenham, Barbara, Muhammad Ali Babar, Mike Berry, et al.. (2006). Evaluating guidelines for empirical software engineering studies. 38–47. 31 indexed citations

10.

Berry, Mike, Beverley Hargadon, M. Shelley, et al.. (2006). Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma. New England Journal of Medicine. 354(7). 697–708. 631 indexed citations breakdown →

11.

Morgan, Angela, Fiona A. Symon, Mike Berry, et al.. (2005). IL-4–expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR3 and CCR4. Journal of Allergy and Clinical Immunology. 116(3). 594–600. 36 indexed citations

12.

Berry, Mike, Natalie Neale, Lucy Woodman, et al.. (2004). Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. Journal of Allergy and Clinical Immunology. 114(5). 1106–1109. 131 indexed citations

13.

Birring, Surinder S., Mike Berry, Christopher E. Brightling, & Ian Pavord. (2003). Eosinophilic Bronchitis. PubMed. 2(2). 169–173. 17 indexed citations

14.

Berry, Mike, et al.. (2003). Innovation by Design: The Economic Drivers of Dynamic Regions. 150. 6 indexed citations

15.

Jeffery, Ross, Victor R. Basili, & Mike Berry. (1994). Establishing measurement for software quality improvement. 319–329. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact